Acetylcysteine

乙酰半胱氨酸

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameAcetylcysteine
Drug Alias Nameacetylcysteinum乙酰半胱胺酸N-acetyl cysteine乙醯半胱氨酸N-乙酰-L-半胱氨酸 +[25] 
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionFree radicals inhibitors
TargetsFree radicals
Therapy Area/IndicationsRejection of renal transplantationDrug intoxicationsCoronavirus Disease 2019 (COVID-19) +[171] 
Global Approved IndicationsPulmonary Disease, Chronic ObstructiveRespiratory Tract DiseasesBronchitis, Chronic
Approved Indications in ChinaPulmonary Disease, Chronic ObstructiveBronchitis, Chronic
Original Approved Country/TerritoryUnited States
Original Approved Date1963/09/14
Country/TerritoryBelgiumBulgariaCanada +[28] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesApothecon Llc
China Registration ClassN/A

Develop Information

Active CompaniesNova Southeastern UniversityUniversity of Texas Southwestern Medical CenterUniversity of California Irvine +[46] 
Inactive CompaniesHeinrich Heine University DusseldorfSandozUniversity Of California San Francisco +[64] 
Active IndicationsDrug intoxicationsCoronavirus Disease 2019 (COVID-19)Lower Respiratory Tract Infections +[75] 
Inactive IndicationsRejection of renal transplantationContrast-induced nephropathySchizophrenia +[96] 

Other Information

ATC CodeR05CB01S01XA08V03AB23
Related LinksWikipediaDrugBankKEGG